Capstone Headwaters Reports: Medical Device Outsourcing Industry Rebounds as Elective Procedures Resume

September 8, 2020

Boston, MA – Capstone Headwaters released its Medical Device Outsourcing update today, reporting that while COVID-19 has severely hampered sales for medical device original equipment manufacturers (OEMs), the resumption of elective surgeries has begun to restore demand for devices and instruments.  U.S. procedure volume stood at 30% of pre-COVID levels at the start of Q2 but has grown to recover near the rate seen at the beginning of the year, according to Intuitive Surgical (Nasdaq:ISRG).

COVID-19 has emphasized the need for scalable manufacturing operations among OEMs, especially those undertaking production related to diagnostic systems and test kits.  Full service contract manufacturing organizations continue to garner increased OEM engagement, especially as supply chain issues remain a top concern.  Outsourced manufacturers that provide sophisticated development and engineering expertise, robust quality and data support, and precision production capability are attractive partners and acquisition targets.

To access the full Medical Device Outsourcing report, click here


Capstone Headwaters is one of the largest and most active independent investment banking firms in the United States.  The firm has a rich 15+ year history of achieving extraordinary results for middle market entrepreneurs, business owners, investors, and creditors.  Capstone offers a fully integrated suite of corporate finance services, including merger & acquisition, debt & equity placement, corporate restructuring, valuation & fairness opinion, financial advisory, and ESOP advisory services.  Headquartered in Boston, the firm has 150+ professionals across 16 offices in the U.S., with and an international presence including over 450 professionals in 40 countries. With 16 dedicated industry groups, the firm delivers sector-specific expertise through large, cross-functional teams on a global basis.  Capstone has been named “U.S. Middle Market Investment Bank of the Year” for the past 9 consecutive years and is consistently recognized as one of the top investment banking firms to work for. For more information, visit

For More Information Contact the Key Report Contributor:

Eric Williams
Managing Director